Abstract
The hypolipidemic drug clofibrate is known to affect the hepatic transport of various organic anions including bilirubin, fatty acids and sulfobromophthalein. Changes in the rate of metabolism and/or intracellular transport have been claimed responsible for the effect. To evaluate these possibilities, the transport of sulfobromophthalein-glutathione, a model compound that does not require metabolism for biliary excretion, was studied in perfused livers isolated from clofibrate-treated and control rats. Cytosolic fatty acid binding protein and glutathione S-transferase activity were also measured. Clofibrate treatment significantly increased liver weight; as a result glutathione S-transferase activity (toward 1-chloro-2,4-dinitrobenzene) fell if expressed per gram of liver (4560±420 (SE) vs 7010±260 nmoles/min for clofibrate treated and controls respectively, p<0.002), but was unchanged when expressed per total liver (60.8±6.5 vs 64.6±3.5 μmoles/min for clofibrate and controls p>0.5). Irrespective of how it was expressed fatty acid binding protein was significantly increased by the drug treatment. Steady state sulfobromophthalein-glutathione removal velocity was saturble with increasing concentrations of sulfobromophthalein-glutathione in both control and clofibrate-treated livers. Steady state extraction ratio, as well as Vmax and Km for removal, did not differ between the two groups. In keeping with other observations, these data collectively indicate that the hepatic steady state removal of nonmetabolized compounds is not affected by clofibrate. Because the concomitant decrease in glutathione S-transferase activity only reflects an opposite change in liver weight, it remains to be determined whether clofibrate alters the hepatic transport of sulfobromophthalein and other compounds that are conjugated with glutathione solely by changing their rate of metabolism.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- BSP:
-
sulfobromophthalein
- BSP-GSH:
-
glutathione conjugate of sulfobromophthalein
- FABPc :
-
cytosolic fatty acid binding protein
- GSH:
-
reduced glutathione
- GSH-transferase:
-
glutathione S-transferase
References
Kutz, K., Schulte, A., Just, C., Lindstaedt, R., and Reiter, B. (1979)Naunyn-Schmiedeberg's Arch. Pharmac. 308, 171–177.
Beckett, R.B., Weiss, R., Stitzel, R.E., and Cenedella, R.J. (1972)Toxicol. Appl. Pharmacol. 23, 42–53.
Crane, D.T., and Masters, C.J. (1986)Biochim. Biophys. Acta 876, 256–263.
Fleischner, G., Meijer, D.K.F., Levine, W.G., Gatmaitan, Z., Gluck, R., and Arias, I.M. (1975)Biochem. Biophys. Res. Commun. 67, 1401–1407.
Bass, N.M., Manning, J.A., Ockner, R.K., Gordon, J.I., Seetharam, S., and Alpers, D.H. (1985)J. Biol. Chem. 260, 1432–1436.
Paulussen, R.J., Jansen, G.P., and Veerkamp, J.H. (1986)Biochim. Biophys. Acta 877, 342–349.
Mounie, J., Goudonnet H., Escousse, A., and Truchot, R.C. (1986)J. Pharmacol. 17, 308–315.
Antonenkov, V.D., Gusev, V.A., and Penchenko, L.F. (1987)Int. J. Biochem. 19, 187–192.
Bronfman, M., Amigo, L., and Morales, M.N. (1986)Biochem. J. 239, 781–784.
Lalwani, N.D., Alvares, K., Reddy, M.K., Reddy, M.N., Parikh, I., and Reddy, J.K. (1987)Proc. Natl. Acad. Sci. USA 84, 5242–5246.
Foliot, A., Touchard, D., and Celier, C. (1984)Biochem. Pharmacol. 33, 2829–2934.
Gartner, U., Stockert, R.J., Levine, W.G., and Wolkoff A.L. (1982)Gastroenterology 83, 1163–1169.
Jean, F., Foliot, A., Celier, C., Hausset, E., and Etienne, J.P. (1979)Biochem. Biophys. Res. Commun. 86, 1154–1160.
Renaud, G., Foliot, A., and Infante, R. (1978)Biochem. Biophys. Res. Commun. 80, 327–334.
Foliot, A., Drocourt, J.L., Etienne, J.P., Housset, E., Fiessinger, J.N., and Christoforov, B. (1977)Biochem. Pharmacol. 26, 547–549.
Kutz, L., Schulte, A., and Reiter B. (1979) (abstract).Gastroenterology 76, 1289.
Kutz, K., Kandler, H., Gugler, R., and Fevery, J. (1984)Clin. Sci. 66, 389–397.
Thielmann, L., Stollman, Y.R., Arias, I.M., and Wolkoff, A.W. (1984)Hepatology 4, 923–926.
Goresky, C.A., Daly, D.S., Mishkin, S., and Arias, I.M. (1978)Am. J. Physiol. 234, E542-E553.
Van Steenbergen, W., Kutz, K., and Fevery, J. (1979) inThe Liver. Quantitative Aspects of Structure and Function. (Preisig R., Bircher J., eds.), pp. 208–212, Editio Cantor, Aulendorf, Germany.
Sorrentino, D., Stremmel, W., and Berk, P.D. (1987)Molec. Asp. Med. 9, 405–428.
Sorrentino, D., and Berk, P.D. (1988)Semin. Liver Dis. 8, 119–136.
Schwarz, L.R., Gotz, R., and Klaassen, C.D. (1980)Am. J. Physiol. 239, C118-C123.
Sorrentino, D., Licko, V., and Weisiger, R.A. (1988)Biochem. Pharmacol. 37, 3119–3126.
Varga, F., Fischer, E., and Szily, T.S. (1974)Biochem. Pharmacol. 23, 2617–2623.
Sorrentino, D., Licko, V., Bass, N.M., and Weisiger, R.A. (1985) (abstract)Gastroenterology 88, 1696.
Whelan, G., Hoch, J., and Combes, B. (1970)J. Lab. Clin. Med. 75, 542–557.
Whelan, G., and Plaa, G.L. (1963)Toxicol. Appl. Pharmacol. 5, 457–463.
Sorrentino, D., Bode, W., and B. Hoener (1987)Biochem. Pharmacol. 36, 915–918.
Wilkinson, G.R. (1987)Pharmacol. Rev. 39, 1–47.
Brissot, P., Wright, T.L., Ma, W.L., and Weisiger, R.A. (1985)J. Clin. Invest. 76, 1463–1470.
Bass, N.M. (1985)Chem. Phys. Lipids 38, 95–114.
Habig, W.G., Pabst, M.J., and Jakoby, W.B. (1974)J. Biol. Chem. 249, 7130–7139.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–275.
Habig, W.H., Pabst, M.J., Fleischner, G., Gatmaitan, Z., Arias, I.M., and Jakoby W.B. (1975)Proc. Natl. Acad. Sci. USA 71, 3879–3882.
Meijer, D.K.F., Bognacki, J., and Levine, W.G. (1975)Naunyn-Schmiedeberg's Arch. Pharmacol. 290, 235–250.
Meijer, D.K.F., Vonk, R.L., Keulemans, K., and Weitering, I.G. (1977)J. Pharm. Exp. Ther. 202, 9–21.
Reddy, J.K., Azarnoff, D.L., and Hignite, CE (1980)Nature 283, 397–398.
Nagini, S., and Nagarajan, B. (1987)Biochem. Intern. 15 703–711.
Svoboda, D.J., Grady, H., and Azarnoff, D.L. (1967)J. Cell Biol. 35, 127–152.
Azarnoff, D.L., and Svoboda, D.J. (1969)Arch. Int. Pharmacodyn. Ther. 181, 386–393.
Yokota, M., Iga, T., Sugiyama, Y., Suyama, A., Awazu, S., and Harrano, M. (1981)J. Pharm. Dyn. 4, 287–293.
Foliot, A., Touchard, D., and Mallet L. (1986)Biochem. Pharmacol. 35, 1685–1690.
Awasthi, Y.C., Singh, S.V., Goel, S.K., and Reddy, J.K. (1984)Biochem. Biophys. Res. Commun. 123, 1012–1018.
Roy-Chowdhury, N., Arias, I.M., Lederstein, M., and Roy-Chowdhury, J. (1986)Hepatology 6, 123–128.
Wolkoff, A.W., Goresky, C.A., Sellin, J., Gatmaitan, Z., and Arias, I.M. (1979)Am. J. Physiol. 236 E638–648.
Bass, N.M., Manning, J.A., and Ockner, R.K. (1985)J. Biol. Chem. 260, 9603–9607.
Sorrentino, D., and Magardino, T. (1989) (abstract) Gastroenterology, in press.
Author information
Authors and Affiliations
About this article
Cite this article
Sorrentino, D., Weisiger, R.A., Bass, N.M. et al. The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver. Lipids 24, 438–442 (1989). https://doi.org/10.1007/BF02535153
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535153